One of the key features of the new Apple Watch Series 4 is the built-in ECG monitoring tool. According to Apple’s announcement, they claim that they were given a De Novo classification by the FDA for the feature, which allowed them to announce it at the event. However it seems that they almost couldn’t.
While many smartwatch makers out there were touting the displays on their devices, Withings made a name for themselves for creating smart wearables that could easily blend in with our daily outfits and not stand out too much. Now after having changed hands again when Nokia sold the company back to its co-founder, they have since launched a new smartwatch.
Apple has been absolutely killing it in the smartwatch game with their Apple Watch, or at least that’s what the numbers seem to tell us. It looks like Apple does not need to worry about getting knocked off their throne anytime soon because according to Apple analyst Ming-Chi Kuo, the Apple Watch Series 4 is reportedly off to a good start.
One of the key features of the Apple Watch Series 4 is how in addition to being able to measure your heart rate, a feature that has been around since the first iteration, it also comes with an ECG feature that basically takes heart measurements to more advanced levels than just how fast your heart is beating.
When Apple announced the Apple Watch Series 4, what many noticed seemed to be missing from the announcement, was the Apple Watch Edition. For those unfamiliar, this was Apple’s way of trying to appeal to customers who wanted a luxurious smartwatch, but now it looks like Apple’s experiment with luxury smartwatches is over.
Apple’s upcoming Apple Watch Series 4 has been rumored to sport a larger display than its predecessor. It turns out the rumors might have been right because in a report from ATH, Apple’s sitemap data has revealed some information about the Apple Watch Series 4 in which it seemingly confirms what we have been hearing so far.
Apple had previously embarked on a study with Stanford Medicine to study how the Apple Watch could be used to detect heart problems. The study seems to be coming to an end and it has been speculated that Apple could be taking what they’ve learnt and apply it to future Apple Watches, which apparently will happen as early as the Apple Watch Series 4.
Recently at IFA 2018, LG took the wraps off its CLOi SuitBot which is an exoskeleton designed to help provide mobility and strength to its wearer. Exoskeletons aren’t exactly new and we have seen how some of them are used in factories to help workers lift heavy objects, and also in the medical field in which it helps patients improve their mobility.
How do you determine when your shoes are about to wear out? There are some who might want a pair of shoes until it literally breaks apart on them, while others might throw out a pair of shoes once the grips on the soles have faded, but it seems that Apple wants a more hi-tech way of solving that “problem”.
Apple’s interest in creating an augmented reality (AR) headset is probably one of the company’s worst-kept secrets. Apart from the rumors, the company has been going about hiring and buying up companies that could help their progress in developing such a device. In fact a recent job listing by Apple points towards that.
If the rumors are to be believed, Apple’s upcoming Apple Watch Series 4 refresh could feature a slightly larger display. However it appears that together with the larger display, Apple will also be bumping up the resolution where according to reports, the smartwatch could feature a slightly higher resolution of 384×480.
We have all heard and read the countless stories in which the Apple Watch and its heart rate sensors have saved a life on more than one occasion, where its alert to users of abnormal heart rates have resulted in many seeking early treatment which allowed them to avoid dying. Researchers also later discovered that the device was adept at detecting heart disease.
#IFA18 – Hearing aids have come a long way since they were first introduced back in the day. For those who have need of such devices, GN has announced the launch of the ReSound LINX Quattro, which according to the company is the “world’s first Premium-Plus” hearing aid solution, and is apparently preferred 95% of the time of music listening.